申请人:Wyeth
公开号:US06451814B1
公开(公告)日:2002-09-17
This invention provides compounds of Formula I having the structure
U, V, W, X, and Y are as defined hereinbefore,
or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.
本发明提供I式化合物,其中U、V、W、X和Y的结构如前所定义,或其药学上可接受的盐,其用于治疗或抑制与胰岛素抵抗或高血糖相关的代谢紊乱(通常与肥胖或葡萄糖不耐症相关),动脉粥样硬化,胃肠道疾病,神经炎症,青光眼,眼压增高和频繁排尿;并且在治疗或抑制II型糖尿病方面特别有用。